Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan E Honeywell

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Visualized Experiments : Jove|February 25, 2025
MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling DataMegan E Honeywell, Michael J Lee
STAR Protocols|March 4, 2021
FLICK: an optimized plate reader-based assay to infer cell death kineticsRyan Richards, Megan E Honeywell, Michael J Lee
Biorxiv : the Preprint Server for Biology|October 24, 2023
Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapyOzen Leylek, Megan E Honeywell, Michael J Lee, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 20, 2024
Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapyOzen Leylek, Megan E Honeywell, Michael J Lee, et al.
Science Signaling|November 18, 2020
ELP-dependent expression of <i>MCL1</i> promotes resistance to EGFR inhibition in triple-negative breast cancer cellsPeter Cruz-Gordillo, Megan E Honeywell, Nicholas W Harper, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Pol II degradation activates cell death independently from the loss of transcriptionNicholas W Harper, Gavin A Birdsall, Megan E Honeywell, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Genome-wide profiling identifies the genetic dependencies of cell death following EGFR inhibitionSydney A Porto, Gavin A Birdsall, Nicholas W Harper, et al.
Cell Reports|June 25, 2020
Drug GRADE: An Integrated Analysis of Population Growth and Cell Death Reveals Drug-Specific and Cancer Subtype-Specific Response ProfilesHannah R Schwartz, Ryan Richards, Rachel E Fontana, et al.
Cell|August 16, 2025
RNA Pol II inhibition activates cell death independently from the loss of transcriptionNicholas W Harper, Gavin A Birdsall, Megan E Honeywell, et al.
Nature Chemical Biology|April 7, 2020
Drug antagonism and single-agent dominance result from differences in death kineticsRyan Richards, Hannah R Schwartz, Megan E Honeywell, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Visualized Experiments : Jove|February 25, 2025
MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling DataMegan E Honeywell, Michael J Lee
STAR Protocols|March 4, 2021
FLICK: an optimized plate reader-based assay to infer cell death kineticsRyan Richards, Megan E Honeywell, Michael J Lee
Biorxiv : the Preprint Server for Biology|October 24, 2023
Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapyOzen Leylek, Megan E Honeywell, Michael J Lee, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 20, 2024
Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapyOzen Leylek, Megan E Honeywell, Michael J Lee, et al.
Science Signaling|November 18, 2020
ELP-dependent expression of <i>MCL1</i> promotes resistance to EGFR inhibition in triple-negative breast cancer cellsPeter Cruz-Gordillo, Megan E Honeywell, Nicholas W Harper, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Pol II degradation activates cell death independently from the loss of transcriptionNicholas W Harper, Gavin A Birdsall, Megan E Honeywell, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Genome-wide profiling identifies the genetic dependencies of cell death following EGFR inhibitionSydney A Porto, Gavin A Birdsall, Nicholas W Harper, et al.
Cell Reports|June 25, 2020
Drug GRADE: An Integrated Analysis of Population Growth and Cell Death Reveals Drug-Specific and Cancer Subtype-Specific Response ProfilesHannah R Schwartz, Ryan Richards, Rachel E Fontana, et al.
Cell|August 16, 2025
RNA Pol II inhibition activates cell death independently from the loss of transcriptionNicholas W Harper, Gavin A Birdsall, Megan E Honeywell, et al.
Nature Chemical Biology|April 7, 2020
Drug antagonism and single-agent dominance result from differences in death kineticsRyan Richards, Hannah R Schwartz, Megan E Honeywell, et al.
Pageof 2